Organization | CareFusion

CareFusion Report issue

For profit Phase 2 Phase 3 Phase 4

Founded: San Diego CA United States (2009)

Status: Acquired by Becton Dickinson (2014)

Organization Overview

First Clinical Trial

2009

NCT00434382

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CareFusion | CAREFUSION 2200

Active Ingredients

Marketed Drugs (1)

chlorhexidine (hibitane) (1988)

Drugs in Phase 4 Trials (3)

chlorhexidine (hibitane) (6 trials)

isopropyl alcohol (3 trials)

povidone-iodine (betadine) (2 trials)

Drugs in Phase 3 Trials (1)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (3)

nivolumab (opdivo) (1 trial)

octenidine (1 trial)

talimogene laherparepvec (Imlygic) (1 trial)

Drugs in Other Trials (8)

alfentanil (alfenta) (1 trial)

desflurane (suprane) (1 trial)

fentanyl (Innovar) (1 trial)

isoflurane (forane) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

sevoflurane (ultane) (1 trial)

sufentanil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Heart Failure (Phase 4)

Infections (Phase 4)

Pleural Effusion (Phase 2)

Pleural Effusion, Malignant (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 15